{"id":"https://openalex.org/W3035430992","doi":"https://doi.org/10.2337/db20-1125-p","title":"1125-P: Association of Plasma Volume with Body Weight and BNP after Long-Term Administration and Subsequent Withdrawal of the SGLT2 Inhibitor Tofogliflozin","display_name":"1125-P: Association of Plasma Volume with Body Weight and BNP after Long-Term Administration and Subsequent Withdrawal of the SGLT2 Inhibitor Tofogliflozin","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3035430992","doi":"https://doi.org/10.2337/db20-1125-p","mag":"3035430992"},"language":"en","primary_location":{"id":"doi:10.2337/db20-1125-p","doi":"https://doi.org/10.2337/db20-1125-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db20-1125-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034811420","display_name":"Yasuhiro Matsubayashi","orcid":"https://orcid.org/0000-0002-2143-1921","observed_orcids":["https://orcid.org/0000-0002-2143-1921"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"YASUHIRO MATSUBAYASHI","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"AKIHIRO YOSHIDA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"AKIHIRO YOSHIDA","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071183903","display_name":"Toshiaki Nojima","orcid":"https://orcid.org/0000-0001-9717-985X","observed_orcids":["https://orcid.org/0000-0001-9717-985X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TOSHIAKI NOJIMA","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012076071","display_name":"Hideki Suganami","orcid":"https://orcid.org/0000-0001-9130-0137","observed_orcids":["https://orcid.org/0000-0001-9130-0137"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HIDEKI SUGANAMI","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101825283","display_name":"Kazuya Fujihara","orcid":"https://orcid.org/0000-0002-9859-389X","observed_orcids":["https://orcid.org/0000-0002-9859-389X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KAZUYA FUJIHARA","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036190568","display_name":"Kohei Kaku","orcid":"https://orcid.org/0000-0003-1574-0565","observed_orcids":["https://orcid.org/0000-0003-1574-0565"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KOHEI KAKU","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037174575","display_name":"Hirohito Sone","orcid":"https://orcid.org/0000-0003-1263-2817","observed_orcids":["https://orcid.org/0000-0003-1263-2817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HIROHITO SONE","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kurashiki, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"69","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.029100000858306885,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tofogliflozin","display_name":"tofogliflozin","score":0.9150000214576721},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/plasma-volume","display_name":"plasma volume","score":0.9829999804496765},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.6940000057220459},{"id":"https://openalex.org/keywords/brain-natriuretic-peptide","display_name":"brain natriuretic peptide","score":0.9589999914169312},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.8240000009536743},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.984000027179718},{"id":"https://openalex.org/keywords/diuresis","display_name":"diuresis","score":0.8519999980926514},{"id":"https://openalex.org/keywords/hyponatremia","display_name":"hyponatremia","score":0.6819999814033508},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.35199999809265137},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.492000013589859},{"id":"https://openalex.org/keywords/blood-urea-nitrogen","display_name":"blood urea nitrogen","score":0.38999998569488525}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7731307744979858},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4778454005718231},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.4572131633758545},{"id":"https://openalex.org/C2779547328","wikidata":"https://www.wikidata.org/wiki/Q584691","display_name":"Diuresis","level":3,"score":0.4148578643798828},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4083138704299927},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.3590572774410248},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.33224526047706604}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db20-1125-p","doi":"https://doi.org/10.2337/db20-1125-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db20-1125-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3137214103","https://openalex.org/W3035196710","https://openalex.org/W2809576948","https://openalex.org/W2903137231","https://openalex.org/W3209787287","https://openalex.org/W2953211847","https://openalex.org/W4400856568","https://openalex.org/W4383481152","https://openalex.org/W4407126482","https://openalex.org/W2967001872"],"abstract_inverted_index":{"SGLT2":[0],"inhibitors":[1],"(SGLT2is)":[2],"promote":[3],"diuresis":[4],"and":[5,16,34,44,69,119,131,164,183,221,235,266],"reduce":[6],"plasma":[7],"volume":[8],"(PV).":[9],"However,":[10],"the":[11,29,38,90],"impact":[12],"of":[13,19,31,37,73,209],"long-term":[14,32,247],"administration":[15,33],"subsequent":[17],"withdrawal":[18,36,74,277],"SGLT2is":[20],"on":[21,42],"PV":[22,43,85,251],"is":[23],"little":[24],"known.":[25],"This":[26],"study":[27],"investigated":[28],"effect":[30],"then":[35],"SGLT2i,":[39],"tofogliflozin":[40],"(TOFO),":[41],"explored":[45,148],"correlations":[46],"with":[47,180,191,201,232,243,256,260],"variables":[48],"in":[49,77,83,204],"type":[50],"2":[51,71,207],"diabetes":[52],"mellitus":[53],"(T2DM).":[54],"Analyzed":[55],"were":[56,198,225],"166":[57],"T2DM":[58],"patients":[59],"who":[60],"received":[61],"TOFO":[62,248,276],"for":[63,150],"52":[64,130,134],"weeks":[65,72,208],"as":[66],"initial":[67],"monotherapy":[68],"underwent":[70],"(week":[75],"54)":[76],"a":[78],"phase-3":[79],"study.":[80],"Percent":[81],"change":[82],"estimated":[84],"(%\u0394ePV)":[86],"was":[87,139,176,188,229,240],"calculated":[88],"by":[89,141,172,281],"Strauss":[91],"formula:":[92],"{100*(pre":[93],"Hb/post":[94],"Hb)*[(100":[95],"-":[96,99,102],"pre":[97],"Ht)/(100":[98],"post":[100],"Ht)]":[101],"100}.":[103],"Baseline":[104],"characteristics":[105],"were:":[106],"male":[107],"(66%),":[108],"age":[109],"(mean:":[110],"58":[111],"y),":[112],"HbA1c":[113],"(8%),":[114],"BMI":[115],"(26kg/m2),":[116],"BNP":[117,166,262,268],"(12pg/mL)":[118],"eGFR":[120],"(84mL/min/1.73m2).":[121],"Paired":[122],"t-tests":[123],"analyzed":[124],"differences":[125],"from":[126,132],"baseline":[127,195,267],"to":[128,135],"week":[129,133,173,217],"54.":[136],"Correlation":[137],"analysis":[138,147],"performed":[140],"Pearson\u2019s":[142],"product-moment":[143],"correlation":[144],"coefficients.":[145],"Multivariate":[146],"predictors":[149],"%\u0394ePV.":[151,205],"Body":[152],"weight":[153,257],"(BW)":[154],"[mean,":[155],"-3kg":[156],"(-5%)*;":[157],"*":[158],"p<0.01":[159],"vs.":[160,216],"baseline],":[161],"ePV":[162,219],"(-2.7%*)":[163],"ln-transformed":[165],"[ln-BNP:":[167],"-0.1ln(pg/mL)*]":[168],"had":[169],"significantly":[170,178,189,226,230,241],"decreased":[171],"52.":[174],"%\u0394BW":[175,228],"not":[177,255],"correlated":[179,190,200,231,242,254],"%\u0394ePV":[181,187,233,239],"(r=-0.06)":[182],"\u0394ln-BNP":[184,192,236,244],"(r=0.13)":[185],"while":[186],"(r=0.35).":[193],"Higher":[194],"ln-BNP":[196,222],"levels":[197],"independently":[199],"greater":[202],"reductions":[203],"After":[206,246],"withdrawal,":[210],"BW":[211],"[+0.9kg":[212],"(+1.3%)\u2020,":[213],"\u2020":[214],"p<0.001":[215],"52],":[218],"(+6.5%\u2020)":[220],"[+0.3ln(pg/mL)":[223],"\u2020]":[224],"increased.":[227],"(r=0.22)":[234],"(r=0.32).":[237],"Also,":[238],"(r=0.30).":[245],"therapy,":[249],"reduced":[250,261],"might":[252,269,278],"be":[253,279],"loss":[258,265],"but":[259],"indicating":[263],"fluid":[264,282],"predict":[270],"changed":[271],"PV.":[272],"Weight":[273],"gain":[274],"after":[275],"caused":[280],"gain.":[283],"Disclosure":[284],"Y.":[285],"Matsubayashi:":[286],"None.":[287,311],"A.":[288],"Yoshida:":[289],"Employee;":[290,297,304],"Self;":[291,298,305,316,326,332,339,374],"Kowa":[292,299,306,350],"Company,":[293,300,307,351],"Ltd.":[294,301,308,336],"T.":[295],"Nojima:":[296],"H.":[302,370],"Suganami:":[303],"K.":[309,312],"Fujihara:":[310],"Kaku:":[313],"Advisory":[314],"Panel;":[315],"Nippon":[317],"Boehringer":[318],"Ingelheim":[319],"Co.":[320,392],"Ltd.,":[321,352,365,379,385,389],"Novo":[322],"Nordisk":[323],"Inc.":[324],"Consultant;":[325],"Sanwa":[327],"Kagaku":[328],"Kenkyusho.":[329],"Research":[330,372],"Support;":[331,373],"Taisho":[333,386],"Pharmaceutical":[334,363,367,383,387,391],"Co.,":[335,364,378,384,388],"Speaker\u2019s":[337],"Bureau;":[338],"Astellas":[340],"Pharma":[341,360],"Inc.,":[342],"AstraZeneca,":[343],"Daiichi":[344],"Sankyo,":[345],"Eli":[346],"Lilly":[347],"Japan":[348],"K.K.,":[349],"Merck":[353],"Sharp":[354],"&":[355],"Dohme":[356],"Corp.,":[357],"Mitsubishi":[358],"Tanabe":[359],"Corporation,":[361],"Ono":[362,382],"Takeda":[366,390],"Company":[368],"Limited.":[369],"Sone:":[371],"Kyowa":[375],"Hakko":[376],"Kirin":[377],"Novartis":[380],"AG,":[381]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2020-06-19T00:00:00"}